About Us
Company Overview
Phase Forward is a leading provider of integrated data collection and data management solutions for clinical trials and drug safety. Our award-winning technology and global services are designed to enable life sciences companies of all types and sizes to automate and integrate the management of their entire clinical development process – from study initiation and FDA submission through post-marketing studies. Our products and services have been used in over 10,000 clinical trials involving more than 1,000,000 trial study participants at over 250 life sciences companies, medical device firms, regulatory agencies and public health organizations.
Phase Forward is a publicly held company (NASDAQ: PFWD) with corporate headquarters in Waltham, Massachusetts, international headquarters in Maidenhead, UK and regional offices in the U.S., Japan, France and Australia.
Realizing the Vision
Phase Forward was founded in 1997 by Paul Bleicher, M.D, Ph.D., who had experienced firsthand the complexities involved in developing and conducting paper-based trials – in particular, capturing and managing growing volumes of data. Dr. Bleicher’s vision was to develop technology that would enable organizations to make the shift from paper-based methods to Internet-enabled solutions. His pioneering efforts have contributed significantly to Phase Forward’s evolution from initial concept to its current industry-leading position.
Spearheading the evolution of electronic data capture (EDC) with its industry-leading InForm™ solution, Phase Forward has fundamentally transformed the way clinical data are collected, analyzed and managed. With the acquisition of Lincoln Technologies’ innovative safety management solutions, we have taken a major step in fulfilling our broader mission: to provide the end-to-end solutions our customers need to track and monitor product efficacy and safety, while building their trials more efficiently and cost-effectively.